Emerging Role of Protein Post-Translational Modification in the Potential Clinical Application of Cancer

被引:5
作者
Xue, Xiangfei [1 ]
Zhang, Xiao [2 ]
Sun, Fenyong [1 ]
Wang, Jiayi [1 ,2 ]
机构
[1] Tongji Univ, Shanghai Peoples Hosp 10, Dept Clin Lab Med, Shanghai 200072, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Inst Thorac Oncol, Shanghai Chest Hosp, 241 West Huaihai Rd, Shanghai 200030, Peoples R China
基金
中国国家自然科学基金;
关键词
Protein post-translational modification; clinical application of cancer; histone modification; detection of cancer; CELL-PROLIFERATION; BREAST-CANCER; PHOSPHORYLATION; UBIQUITINATION; ACETYLATION; EXPRESSION; SUMOYLATION; METHYLATION; PROGRESSION;
D O I
10.1142/S17939844200200085
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Cancer, one of the largest public health problems in the world, greatly endangers human health. Every country in the world faces a significant burden due to cancer. Protein post-translational modification (PTM) plays a very important role in life. PTM makes the structure of proteins more complex and the functions more perfect. Common PTM processes include methylation, acetylation, phosphorylation, glycosylation and ubiquitination. In this paper, we introduce several common types of PTMs that were discovered in recent years in various cancer types, especially the early stages of cancer, and we explore the role of related molecules in cancer screening, diagnosis, disease surveillance and prognosis. We look forward to using PTM-relevant molecules as markers for the early diagnosis of cancer, after further in-depth research and large-scale clinical trials, to contribute to the early and accurate diagnosis of cancer, thereby improving the prognosis.
引用
收藏
页数:12
相关论文
共 61 条
  • [1] Protein methylation: a signal event in post-translational modification
    Aleta, JM
    Cimato, TR
    Ettinger, MJ
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1998, 23 (03) : 89 - 91
  • [2] Post-Translational Protein Modifications of Rare and Unconventional Types: Implications in Functions and Diseases
    Basak, Sarmistha
    Lu, Chunyu
    Basak, Ajoy
    [J]. CURRENT MEDICINAL CHEMISTRY, 2016, 23 (07) : 714 - 745
  • [3] Bawa-Khalfe T, 2017, ONCOTARGET, V8, P17651, DOI 10.18632/oncotarget.13283
  • [4] SUMO proteases as potential targets for cancer therapy
    Bialik, Piotr
    Wozniak, Katarzyna
    [J]. POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2017, 71 : 997 - 1004
  • [5] Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation
    Borbone, E.
    Berlingieri, M. T.
    De Bellis, F.
    Nebbioso, A.
    Chiappetta, G.
    Mai, A.
    Altucci, L.
    Fusco, A.
    [J]. ONCOGENE, 2010, 29 (01) : 105 - 116
  • [6] Cancer Statistics in China, 2015
    Chen, Wanqing
    Zheng, Rongshou
    Baade, Peter D.
    Zhang, Siwei
    Zeng, Hongmei
    Bray, Freddie
    Jemal, Ahmedin
    Yu, Xue Qin
    He, Jie
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) : 115 - 132
  • [7] Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis
    Chen, Xingcheng
    Stauffer, Seth
    Chen, Yuanhong
    Dong, Jixin
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (28) : 14761 - 14772
  • [8] ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis
    Chen, Yan
    Zhang, Bo
    Bao, Lei
    Jin, Lai
    Yang, Mingming
    Peng, Yan
    Kumar, Ashwani
    Wang, Jennifer E.
    Wang, Chenliang
    Zou, Xuan
    Xing, Chao
    Wang, Yingfei
    Luo, Weibo
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (05) : 1937 - 1955
  • [9] Cronin KA, 2018, Cancer, V124, P2785
  • [10] Specific expression of k63-linked ubiquitination of calmodulin-like protein 5 in breast cancer of premenopausal patients
    Debald, Manuel
    Schildberg, Frank Alexander
    Linke, Andrea
    Walgenbach, Klaus
    Kuhn, Walther
    Hartmann, Gunther
    Walgenbach-Bruenagel, Gisela
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (12) : 2125 - 2132